Phenotypic and Genotypic Detection of Colistin Resistance
NCT07487116 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 90
Last updated 2026-03-23
Summary
* Evaluation of the disk elution test as reliable routine method for detection of colistin resistant among multidrug resistant gram-negative bacteria compared with broth microdilution.
* Molecular detection of colistin resistant in multidrug-resistant gram-negative bacteria.
Conditions
- Patients With Multi Drug Resistant Gram-negative Bacteria
- Colistin Resistance in Bacteria
Interventions
- DIAGNOSTIC_TEST
-
disk elution test
* Identification of microorganism using conventional methods or Vitek 2 compact system. * Anti biotic susceptibility test using conventional methods or Vitek 2 compact system. * For MDR gram negative bacteria: disc elution test and colistin broth microdilution
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-31
- Primary Completion
- 2029-08-31
- Completion
- 2029-08-31
More Related Trials
-
Safety and Efficacy Study of High Dose Colistin
NCT02162966 ·Status: UNKNOWN ·Phase: PHASE4
-
Colistin-rifampin Combination and Colistin Monotherapy in Extensively Drug-resistant Acinetobacter Baumannii
NCT03622918 ·Status: COMPLETED ·Phase: NA
-
Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections
NCT06843668 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Colistin Intravenous Administration in Critically Ill Patients Suffering From Hospital Infections Caused by Multi-antibiotic-resistant Germs.
NCT04995133 ·Status: UNKNOWN ·Phase: PHASE4
-
Rapid Antimicrobial Susceptibility Testing with MIC Directly from Positive Blood Cultures with ASTar
NCT06218277 ·Status: COMPLETED ·Phase: NA
-
Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
NCT01732250 ·Status: COMPLETED ·Phase: PHASE4
-
Colistin and Rifampicin for MDR-Acinetobacter
NCT01577862 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Aerosolised Colistin in Ventilator Associated Pneumonia
NCT02683603 ·Status: COMPLETED ·Phase: PHASE4
-
Optimizing Dosing of Colistin for Infections Resistant to All Other Antibiotics, Approved NIH Protocol Dated 12.06.07(DMID Protocol #07-0036)
NCT00235690 ·Status: COMPLETED ·Phase: NA
-
Colistin Versus Colistin Plus Fosfomycin for Infections Caused by MDR Acinetobacter Baumannii
NCT01297894 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Colistin Monotherapy Versus Colistin Plus Minocycline for Carbapenem-Resistant A. Baumannii Infection
NCT05586815 ·Status: UNKNOWN ·Phase: PHASE4
-
Antibiogram and Biofilm Formation of Bacteria Causing Prosthetic Joint Infections Isolated From Assiut University Hospital
NCT05239312 ·Status: UNKNOWN
-
Trial of Colistin Versus Meropenem in Ventilator-associated Pneumonia (VAP) (CR-GNB)
NCT01292031 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Plasma Levels of Colistin in Patients With Carbapenem Resistant Acinetobacter Baumannii Infection
NCT02482961 ·Status: COMPLETED
-
Efficacy and Safety of Colistin for Therapy of Infections Caused by ESBL Producing K.Pneumoniae or E.Coli
NCT00300560 ·Status: UNKNOWN ·Phase: PHASE3
-
Discontinuation of Antibiotic Susceptibility Testing on Enterococcus Faecalis Positive Urine Cultures in Hospitalized Patients: an Impact on Antibiotic Prescriptions? (FaecaCible)
NCT05743192 ·Status: COMPLETED
-
Effect of Different Colistin Doses on Clinical Outcome of Pediatric Cancer Patients With Gram Negative Infections
NCT03397914 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae
NCT04489459 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Study of Clinical Outcomes and Safety Between Colistin and Tigecycline
NCT06893835 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Efficacy and Mortality of a Loading Dose of Colistin in Critical Ill Patients
NCT02117986 ·Status: UNKNOWN ·Phase: PHASE4
-
Carbapenem and Quinolone Resistance in Klebsiella Pneumoniae
NCT03767283 ·Status: UNKNOWN
-
Clinical Outcomes With Ceftolozane-tazobactam for MDR Pseudomonas Infections
NCT03510351 ·Status: COMPLETED
-
Selective Reporting of Antibiotic Susceptibility Test Results in Urinary Tract Infections in the Outpatient Setting
NCT03612297 ·Status: UNKNOWN
-
Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection
NCT06051513 ·Status: RECRUITING ·Phase: NA
-
Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis
NCT02556190 ·Status: COMPLETED